Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.

[1]  R. Somech,et al.  Matched unrelated bone marrow transplant for T+ combined immunodeficiency , 2008, Bone Marrow Transplantation.

[2]  C. Dvorak,et al.  Hematopoietic stem cell transplantation for primary immunodeficiency disease , 2008, Bone Marrow Transplantation.

[3]  D. Rizzieri,et al.  Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  P. Reddy,et al.  Pathophysiology of acute graft-versus-host disease: recent advances. , 2007, Translational research : the journal of laboratory and clinical medicine.

[5]  L. Notarangelo,et al.  Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. , 2007, The Journal of allergy and clinical immunology.

[6]  W. Friedrich,et al.  Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation , 2007, Immunologic research.

[7]  J. Mehta,et al.  Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation , 2007, Bone Marrow Transplantation.

[8]  N. Novitzky,et al.  Allogeneic stem cell transplantation with T cell-depleted grafts for lymphoproliferative malignancies. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  L. Notarangelo,et al.  Bone marrow transplantation for severe combined immune deficiency. , 2006, JAMA.

[10]  C. Chapman,et al.  Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency , 2005, Bone Marrow Transplantation.

[11]  P. Debré,et al.  NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. , 2005, Blood.

[12]  A. Fischer,et al.  Severe combined immunodeficiency. A model disease for molecular immunology and therapy , 2005, Immunological reviews.

[13]  R. Buckley Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. , 2004, Annual review of immunology.

[14]  R. Gelman,et al.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. , 2003, The Journal of allergy and clinical immunology.

[15]  Y. Bertrand,et al.  Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors , 2003, Bone Marrow Transplantation.

[16]  A. Fischer,et al.  Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 , 2003, The Lancet.

[17]  G. Hale,et al.  Immune reconstitution at 6 months following t-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome , 2002, Transplantation.

[18]  R. Handgretinger,et al.  A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells , 2002, Bone Marrow Transplantation.

[19]  J. Puck,et al.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. , 2002, Blood.

[20]  M. Horowitz,et al.  Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[21]  G. Spickett,et al.  CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center. , 2001, Cytotherapy.

[22]  T. Klingebiel,et al.  Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children , 2001, Bone Marrow Transplantation.

[23]  K. Weinberg,et al.  T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency. , 2000, Archivum immunologiae et therapiae experimentalis.

[24]  A. Fischer,et al.  Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients. , 1999, Blood.

[25]  S. Müller,et al.  Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. , 1999, The Journal of pediatrics.

[26]  J. Roberts,et al.  Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 1999, The New England journal of medicine.

[27]  M. Abinun,et al.  In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID) , 1997, Bone Marrow Transplantation.

[28]  M. V. van Tol,et al.  Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. , 1994, Blood.

[29]  R. Soiffer,et al.  Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation. , 1993, Blood.

[30]  D. Wara,et al.  Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. , 1993, Blood.

[31]  J. Hansen,et al.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.

[32]  A. Freedman,et al.  Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. , 1992, Journal of Clinical Oncology.

[33]  A. Fischer,et al.  European experience of bone-marrow transplantation for severe combined immunodeficiency , 1990, The Lancet.

[34]  J. Ritz,et al.  Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation. , 1990, Blood.

[35]  T. Small,et al.  The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. , 1989, Immunodeficiency reviews.

[36]  B. Dupont,et al.  Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. , 1986, Blood.

[37]  J. Ritz,et al.  Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis. , 1986, Transplantation.

[38]  A. Huang,et al.  Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. , 1986, Journal of immunology.

[39]  R. Warnke,et al.  Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. , 1985, The New England journal of medicine.

[40]  B. Dupont,et al.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. , 1983, Blood.

[41]  E. Reinherz,et al.  Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Reinherz,et al.  A monoclonal antibody reactive with human peripheral blood monocytes. , 1980, Journal of immunology.